Stock Events

Stock Events

FEG 

HK$0.32
0
+HK$0.01+4.84% Friday 01:30

Statistics

Day High
0.36
Day Low
0.31
52W High
0.63
52W Low
0.26
Volume
2,366,000
Avg. Volume
-
Mkt Cap
94.84M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

9AugExpected
Q2 2021
Q3 2021
Q1 2022
Q3 2022
Q2 2024
-0.01
0.01
0.02
0.04
Expected EPS
N/A
Actual EPS
N/A

Financials

-624.04%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
11.17MRevenue
-69.73MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 1413.HK. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
GSK
GSK
Mkt Cap117.55B
GlaxoSmithKline plc is a major player in the pharmaceuticals sector, competing in various therapeutic areas similar to Regent Pacific.
Pfizer
PFE
Mkt Cap156.77B
Pfizer Inc. operates in the global pharmaceutical market, directly competing in the development and marketing of medical solutions.
Novartis
NVS
Mkt Cap293.34B
Novartis AG is known for its extensive research and development in pharmaceuticals, overlapping with Regent Pacific's market interests.
Merck
MRK
Mkt Cap294.39B
Merck & Co., Inc. competes in the pharmaceutical industry, focusing on innovative therapies where Regent Pacific also operates.
Johnson & Johnson
JNJ
Mkt Cap564.35B
Johnson & Johnson offers a broad range of health products, competing across several of the same therapeutic areas as Regent Pacific.
Abbvie
ABBV
Mkt Cap368.57B
AbbVie Inc. engages in the development of pharmaceutical products, directly competing with Regent Pacific in specific therapeutic categories.
AMGEN
AMGN
Mkt Cap191.53B
Amgen Inc. focuses on biotechnological medicines, including areas that overlap with Regent Pacific's product lines.
Bristol-Myers Squibb
BMY
Mkt Cap122.85B
Bristol-Myers Squibb Company operates in the global biopharmaceutical market, competing in the same sphere as Regent Pacific.
Sanofi
SNY
Mkt Cap115.14B
Sanofi focuses on pharmaceuticals and treatments that compete with Regent Pacific's products in various global markets.
Astrazeneca
AZN
Mkt Cap317.5B
AstraZeneca PLC competes in the pharmaceutical sector, developing drugs in areas that potentially compete with Regent Pacific's offerings.

About

Kwong Luen Engineering Holdings Limited, together with its subsidiaries, operates as a foundation works contractor in Hong Kong. It primarily undertakes excavation and lateral support, pile cap construction, underground drainage, and site formation works. The company was founded in 1995 and is headquartered in Tsuen Wan, Hong Kong.
Show more...
CEO
Mr. Kwong Cheung Yip
Employees
140
Country
Hong Kong
ISIN
KYG5329A1031

Listings

HK
HK
575.HK
STU
DE
RPG.STU
HK
HK
1239.HK
HK
HK
559.HK

0 Comments

Share your thoughts

FAQ

What is FEG stock price today?▼
The current price of 1413.HK is HK$0.32 HKD — it has increased by +4.84% in the past 24 hours. Watch FEG stock price performance more closely on the chart.
What is FEG stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange FEG stocks are traded under the ticker 1413.HK.
What is FEG market cap?▼
Today FEG has the market capitalization of 94.84M
What is FEG revenue for the last year?▼
FEG revenue for the last year amounts to 11.17M HKD.
What is FEG net income for the last year?▼
1413.HK net income for the last year is -69.73M HKD.
How many employees does FEG have?▼
As of April 27, 2026, the company has 140 employees.
In which sector is FEG located?▼
FEG operates in the Manufacturing sector.
When did FEG complete a stock split?▼
The last stock split for FEG was on December 16, 2025 with a ratio of 1:5.
Where is FEG headquartered?▼
FEG is headquartered in Tsuen Wan, Hong Kong.